Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma

J. Muller, O. Krijgsman, J. Tsoi, L. Robert, W. Hugo, C. Song, X. Kong, P.A. Possik, P. Cornelissen-Steijger, M.H. Foppen, K. Kemper, C.R. Goding, U. McDermott, C. Blank, J. Haanen, T.G. Graeber, A. Ribas, R.S. Lo, D.S. Peeper

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number5712
JournalNature Communications
Volume5
DOIs
Publication statusPublished - 2014

Cite this

Muller, J., Krijgsman, O., Tsoi, J., Robert, L., Hugo, W., Song, C., ... Peeper, D. S. (2014). Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma. Nature Communications, 5, [5712]. https://doi.org/10.1038/ncomms6712